Reprograming T cells to attack solid tumors

by Agency for Science, Technology and Research (A*STAR), SingaporeA colourful battle: Live human liver cancer cells (green) are attacked by engineered T cells (blue), resulting in a dead liver ca

Updated on: April 07,2024

Reprograming T cells to attack solid tumors

by Agency for Science, Technology and Research (A*STAR), SingaporeA colourful battle: Live human liver cancer cells (green) are attacked by engineered T cells (blue), resulting in a dead liver ca

Updated on:April 07,2024

AI in personalized cancer medicine: New therapies require flexible and safe approval conditions

by Viktoria Bosak,Dresden University of TechnologyA perspective on the US and EU regulatory system readiness for AI-enabled personalized drug and cell-based therapies in precision oncology. The

Updated on: March 05,2024

AI in personalized cancer medicine: New therapies require flexible and safe approval conditions

by Viktoria Bosak,Dresden University of TechnologyA perspective on the US and EU regulatory system readiness for AI-enabled personalized drug and cell-based therapies in precision oncology. The

Updated on:March 05,2024

And improved method for anti-cancer drug detection: How tiny tumor models could transform drug testing

by Songshan Lake Materials LaboratorySchematic of microfluidic chip-based approach for quality assessment and screening of esophageal cancer drugs. A three-dimensional scaffold with inverse opal struc

Updated on: August 03,2024

And improved method for anti-cancer drug detection: How tiny tumor models could transform drug testing

by Songshan Lake Materials LaboratorySchematic of microfluidic chip-based approach for quality assessment and screening of esophageal cancer drugs. A three-dimensional scaffold with inverse opal struc

Updated on:August 03,2024

Anticancer immunity through tumor antigen identification and conversion to DNA vaccines

by The Wistar InstituteCredit: CC0 Public DomainWistar scientists and collaborators demonstrated the utility of an optimized synthetic DNA vaccine platform for rapidly inducing immunity against u

Updated on: March 12,2024

Anticancer immunity through tumor antigen identification and conversion to DNA vaccines

by The Wistar InstituteCredit: CC0 Public DomainWistar scientists and collaborators demonstrated the utility of an optimized synthetic DNA vaccine platform for rapidly inducing immunity against u

Updated on:March 12,2024

Women with breast cancer shed pounds thanks to telephone-based weight loss program, clinical trial finds

by Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainWomen with obesity when they are diagnosed with early breast cancer have a higher risk of recurrence or a second cancer compared to

Updated on: January 30,2024

Women with breast cancer shed pounds thanks to telephone-based weight loss program, clinical trial finds

by Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainWomen with obesity when they are diagnosed with early breast cancer have a higher risk of recurrence or a second cancer compared to

Updated on:January 30,2024

Researchers identify cancer killing capability of lesser-known immune cells

by Trinity College DublinResearch Assistant Professor at TTMI and Principal Investigator, Dr Margaret Dunne. Credit: Moya Nolan.Researchers at Trinity College Dublin have identified, for the firs

Updated on: June 19,2024

Researchers identify cancer killing capability of lesser-known immune cells

by Trinity College DublinResearch Assistant Professor at TTMI and Principal Investigator, Dr Margaret Dunne. Credit: Moya Nolan.Researchers at Trinity College Dublin have identified, for the firs

Updated on:June 19,2024

Study reveals CREB3's role in hepatocellular carcinoma suppression via AKT signaling

by Sichuan International Medical Exchange and Promotion AssociationExpression of CREB3 is decreased in HCC tissues and correlated with better clinical outcome. (A) mRNA expression of CREB3 in HCC tiss

Updated on: July 05,2024

Study reveals CREB3's role in hepatocellular carcinoma suppression via AKT signaling

by Sichuan International Medical Exchange and Promotion AssociationExpression of CREB3 is decreased in HCC tissues and correlated with better clinical outcome. (A) mRNA expression of CREB3 in HCC tiss

Updated on:July 05,2024

Special RNA shown to suppress the formation of breast cancer cells

JANUARY 16, 2024by Sebastian Hollstein,Friedrich Schiller University of JenaCredit:Cell Reports(2024). DOI: 10.1016/j.celrep.2023.113644Breast cancer is the most common cancer in wom

Updated on: March 25,2024

Special RNA shown to suppress the formation of breast cancer cells

JANUARY 16, 2024by Sebastian Hollstein,Friedrich Schiller University of JenaCredit:Cell Reports(2024). DOI: 10.1016/j.celrep.2023.113644Breast cancer is the most common cancer in wom

Updated on:March 25,2024

A new targeted treatment shows promise for select patients with stomach cancer

byWeill Cornell Medical CollegeCredit: Pixabay/CC0 Public DomainAn international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, has found tha

Updated on: January 29,2024

A new targeted treatment shows promise for select patients with stomach cancer

byWeill Cornell Medical CollegeCredit: Pixabay/CC0 Public DomainAn international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, has found tha

Updated on:January 29,2024

Characterization of mutational 'coldspots' in the cancer genome

byInstitute for Research in Biomedicine (IRB Barcelona)Credit: Pixabay/CC0 Public DomainMutations are the changes in the DNA that gradually occur in human cells as they replicate, and the organi

Updated on: April 28,2024

Characterization of mutational 'coldspots' in the cancer genome

byInstitute for Research in Biomedicine (IRB Barcelona)Credit: Pixabay/CC0 Public DomainMutations are the changes in the DNA that gradually occur in human cells as they replicate, and the organi

Updated on:April 28,2024

Minimal residual disease negativity predicts time to next treatment in multiple myeloma

by Elana GotkineFor patients with multiple myeloma (MM), minimal residual disease (MRD) negativity determined using next-generation sequencing (NGS) is predictive of longer time to next treatment (TTN

Updated on: January 22,2024

Minimal residual disease negativity predicts time to next treatment in multiple myeloma

by Elana GotkineFor patients with multiple myeloma (MM), minimal residual disease (MRD) negativity determined using next-generation sequencing (NGS) is predictive of longer time to next treatment (TTN

Updated on:January 22,2024

Long-lasting radionuclide therapy for advanced neuroendocrine tumors proves effective

by Society of Nuclear Medicine and Molecular ImagingScans were done at 2, 24, 72, 120 and 168 hours after the administration of177Lu-DOTA-EB-TATE. The radiopharmaceutical cleared from the blood

Updated on: April 18,2024

Long-lasting radionuclide therapy for advanced neuroendocrine tumors proves effective

by Society of Nuclear Medicine and Molecular ImagingScans were done at 2, 24, 72, 120 and 168 hours after the administration of177Lu-DOTA-EB-TATE. The radiopharmaceutical cleared from the blood

Updated on:April 18,2024